Bioxyne Ltd (PR8)
Market Closed
XSTU XSTU Primary €
€
- Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
€
Previous Close Want to track PR8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bioxyne Ltd (PR8) Statistics
Valuation metrics
Market Cap -
Enterprise value -354.27K
Trailing P/E (ttm) -
Forward P/E -
PEG ratio -
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -0.04
Enterprise Value/EBITDA -0.04
Overview
Shares outstanding 2.05B
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.33K
Average volume (90 days) 203.75K
Price summary
52-Week low -
52-Week high -
Beta -
50-Day moving average -
200-Day moving average -
Financials
Fiscal year
Fiscal year ends 30 Jun 2024
Most recent quarter (mrq) 30 Jun 2024
Profitability
Profit margin 0.36%
Operating margin -0.18%
Operational effectiveness
Return on assets -1.99%
Return on equity -4.04%
Income Statement
Revenue (ttm) 9.33M
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) 3.4M
EBITDA 9.91M
Net income to common (ttm) -13.33M
Diluted EPS (ttm) -
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.03M
Total cash per share (mrq) -
Total debt (mrq) 673.72K
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 1.92%
Book value per share (mrq) -
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -13.33M
